Ligand validation:7PLB

XYP: beta-D-xylopyranose

XYP is a Ligand Of Interest in 7PLB designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7PLB_XYP_A_303	76%	56%	0.085	0.92	0.61	1.07	-	1	0	0	100%	1
7PLB_XYP_A_305	64%	60%	0.124	0.921	0.58	0.93	-	1	0	0	100%	1
7PLB_XYP_A_304	39%	63%	0.162	0.867	0.57	0.85	-	1	0	0	100%	1
7PLB_XYP_B_304	32%	60%	0.186	0.857	0.57	0.95	-	1	0	0	100%	1
7PLB_XYP_B_302	29%	57%	0.174	0.831	0.62	1.03	-	2	0	0	100%	1
7PLB_XYP_B_305	20%	54%	0.205	0.807	0.59	1.16	-	2	0	0	100%	1
7PLC_XYP_D_302	65%	60%	0.114	0.916	0.58	0.95	-	1	0	0	100%	1
1OD8_XYP_A_1311	100%	64%	0.047	0.992	0.75	0.64	-	-	0	0	100%	1
1V0M_XYP_A_1304	100%	71%	0.035	0.993	0.82	0.33	-	-	0	0	90%	0.9
8Y00_XYP_D_201	99%	28%	0.032	0.986	0.63	2.19	-	7	1	0	90%	0.9
2WYS_XYP_A_1001	99%	38%	0.052	0.983	0.69	1.7	-	4	3	0	100%	1
1V0N_XYP_A_1306	98%	60%	0.048	0.989	0.76	0.78	-	-	0	0	90%	0.9

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.